These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4363816)

  • 21. Adverse interaction between acetazolamide and anticholinesterase drugs at the normal and myasthenic neuromuscular junction level.
    Carmignani M; Scoppetta C; Ranelletti FO; Tonali P
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):140-4. PubMed ID: 6715082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-ouabain action of steroid hormones on twitch and potassium contracture in heart ventricle strip of frog.
    Fujino S; Yorozuya S; Izumi T; Tanaka M
    Jpn J Pharmacol; 1969 Mar; 19(1):148-56. PubMed ID: 5306213
    [No Abstract]   [Full Text] [Related]  

  • 23. Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography.
    Schwartz MS; Stålberg E
    Neurology; 1975 Jan; 25(1):80-4. PubMed ID: 1167410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.
    Dandona P; Corkan EJ; Sladen GE
    Postgrad Med J; 1977 Jun; 53(620):321-4. PubMed ID: 887530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant.
    Ellis KO; Carpenter JF
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(1):83-94. PubMed ID: 4344329
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic agents for alleviation of muscle weakness in myasthenia gravis (cholinesterase inhibitors)].
    Streller I
    Arzneimittelforschung; 1981; Suppl 27():73-5. PubMed ID: 7197942
    [No Abstract]   [Full Text] [Related]  

  • 29. Myasthenia gravis and glycopyrrolate.
    Marcus E; Wayne F
    S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
    Ellis KO; Carpenter JF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898
    [No Abstract]   [Full Text] [Related]  

  • 31. pPy: a measure of potentiating activity.
    Edge ND
    Nature; 1967 Dec; 216(5119):1014-5. PubMed ID: 6066547
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis for the effect of different regimens on ocular myasthenia gravis in children].
    Liu C; Wang X; Xie L; Peng J; Wu L; Zheng X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1275-1279. PubMed ID: 29187654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hormones on muscle action potentials, contractions and temperature in rats.
    Strand FL; Stoboy H
    Pflugers Arch; 1969; 312(1):R97. PubMed ID: 4311374
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW
    Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the effects of neuromuscular blocking agents and cholinesterase inhibitors on the tibialis anterior and superior rectus muscles of the cat.
    Katz RL; Eakins KE
    J Pharmacol Exp Ther; 1966 May; 152(2):304-12. PubMed ID: 5944372
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of alpha,alpha'-bis-(dimethylammoniumacetaldehyde diethylacetal)-p,p'-diacetylbiphenyl bromide (DMAE) on neuromuscular transmission.
    Chiou CY; Long JP
    J Pharmacol Exp Ther; 1969 Jun; 167(2):344-50. PubMed ID: 4306905
    [No Abstract]   [Full Text] [Related]  

  • 39. Myasthenic myopathy and thymoma.
    Rowland LP; Lisak RP; Schotland DL; DeJesus PV; Berg P
    Neurology; 1973 Mar; 23(3):282-8. PubMed ID: 4735179
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the effectiveness of cholinolytics as antidotes in poisoning with anticholinesterase compounds of mice and rats].
    Prozorovskiĭ VB
    Farmakol Toksikol; 1968; 31(5):553-6. PubMed ID: 4387719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.